The findings of the VenUS IV trial confirm that hosiery kits can now be seen as a viable first-line option for the treatment of VLUs in suitable patients. This Making the Case focuses on the clinical, economic and patient benefits of using ActiLymph/Activa Leg Ulcer Hosiery Kits and how 2-layer hosiery lead to improved patient concordance with compression therapy.

Supported by Activa Healthcare